Atlanta Gastroenterology Associates Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00495391
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

certolizumab pegol (cimzia) (1 trial)

Drugs in Phase 2 Trials (3)

interferon alpha-2b (Intron-A) (2 trials)

nitazoxanide (Alinia) (2 trials)

ribavirin (virazole) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4